Treatment
Treatment clinical trials
We’re tracking 8,322 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT07270276Recruiting
Dry needling for shoulder muscle pain
This study tests if dry needling (a therapy that uses thin needles to release muscle knots) can help with shoulder muscle pain. It uses special tests to measure how the treatment affects your muscles and pain.
Boston, MassachusettsAges 18–80 - NCT07271485RecruitingEarly Phase 1
Propranolol for misophonia: a pilot study
This trial tests if a blood pressure medication called propranolol can reduce the intense anger or anxiety some people feel in response to everyday sounds (like chewing or breathing). If you have misophonia and meet the study’s health and safety criteria, you may be able to join and receive the medication under medical supervision at a clinic in Littleton, Colorado.
Littleton, ColoradoAges 18–65 - NCT07270549RecruitingPhase 1/Phase 2
Gene therapy trial for children with CTNNB1 syndrome
This trial tests a one-time gene replacement therapy given into the fluid around the brain to help children with CTNNB1 neurodevelopmental syndrome. The goal is to see if replacing the faulty gene can improve development and reduce symptoms.
LjubljanaAges 2–12 - NCT07270406Recruiting
Healthy habits for better sleep in people with HIV and pain
This study tests a healthy behaviors program to help prevent insomnia in people with HIV who also have ongoing pain. If you have trouble sleeping and chronic pain, this program may help improve your sleep and well-being.
St Louis, MissouriAges 25–65 - NCT07270575Recruiting
Resorbable stents for leg artery disease with limb threat
This trial tests a special scaffold that slowly releases medicine to open blocked arteries below the knee. It is for people whose leg pain or wounds are severe enough to threaten the limb.
HullAges 18 years+ - NCT07269548Recruiting
Healing of pilonidal cyst after 1940 nm laser treatment
This study checks how well a pilonidal cyst heals after treatment with a special laser (1940 nm). It looks at your recovery after the surgery to see if the laser helps the wound close properly.
LyonAges 18 years+ - NCT07275697RecruitingPhase 4
Weight loss drug and heart ablation study for AFib
This trial tests whether a weight loss medication (semaglutide) given before and after a first-time heart ablation procedure for atrial fibrillation can improve outcomes. It is for people who are overweight or obese and have certain related health conditions.
StockholmAges 18 years+ - NCT07276932Recruiting
Acupoint paste for constipation after chemo
This study tests whether applying a special paste to acupoints (specific points on your body) can help relieve constipation and boost energy (qi) in people with colorectal cancer who've had chemotherapy. It's for patients who feel weak and have trouble with constipation after treatment.
Hangzhou, ZhejiangAges 18 years+ - NCT06891742RecruitingPhase 1
A study of a new cell therapy for advanced liver cancer
This trial tests a new treatment called OriC902 for people with advanced liver cancer (HCC) that has not responded to standard therapies. The treatment uses special immune cells designed to target a protein called GPC3 found on cancer cells. The goal is to see if this approach can help shrink tumors or stop them from growing.
Beijing, Beijing MunicipalityAges 18–75 - NCT06604117Recruiting
Probucol and statins for recent ischemic stroke
This trial tests whether adding probucol to statin therapy can help people who recently had an ischemic stroke caused by hardened arteries. The goal is to see if this combination works better than statins alone for preventing future strokes.
Xicheng District, Beijing MunicipalityAges 18 years+ - NCT06890858RecruitingPhase 2
Fasudil for ovarian cancer with A/A gene type
This trial tests if adding fasudil hydrochloride to your current chemotherapy can help when ovarian cancer has stopped responding to platinum-based chemo. It is for people whose tumor has a specific gene pattern called A/A.
Hangzhou, ZhejiangAges 18 years+ - NCT05776342Recruiting
Markers study for treatment response in pancreatic cancer
This study looks at tumor “markers” (tests on cancer tissue or related information) to understand how you may respond to first-line treatment for pancreatic cancer. Your results may help doctors better predict which treatments work best for different people.
BesançonAges 18 years+ - NCT06391125RecruitingPhase 3
Lidocaine for pain relief with penicillin shot for syphilis
This study tests if adding a numbing medicine (lidocaine) to a penicillin shot reduces the pain of the injection for people being treated for syphilis. If you are starting your first of three weekly penicillin shots, you may be able to join.
St Louis, MissouriAges 18 years+ - NCT06671106Recruiting
Mouthrinse for Teens with Early Gum Disease
This trial tests a special mouthrinse containing amine and zinc lactate to treat plaque-induced gingivitis (gum inflammation caused by plaque) in teenagers. If you or your teen have early gum disease and are eligible for free dental care through the Regional Health Service, this study may offer a home-based treatment option.
FerraraAges 12–14 - NCT06728241Recruiting
Virtual reality and AI therapy for psychosis
This study tests if virtual reality and artificial intelligence can help people with psychosis overcome difficulties going outside or doing everyday activities. It uses VR scenarios and AI tools to support treatment.
Oslo, NorwayAges 17–65 - NCT06894173Recruiting
Early breast cancer treatment evolution study
This study looks back at treatments given to people with triple-negative or HER2-positive early breast cancer between 2016 and 2021. It aims to understand how treatment approaches have changed over time.
Aviano, PNAges 18 years+ - NCT06894576Recruiting
Creating a risk score for blood clot recurrence and bleeding in cancer patients
This study is for people with cancer who have had a serious blood clot. Researchers want to create a risk score that predicts who might have another clot or a bleeding problem from treatment, so they can better tailor care.
Ottawa, OntarioAges 18 years+ - NCT06766266RecruitingPhase 1
Irinotecan and Epirubicin for recurring bladder cancer
This trial tests a combination of two chemotherapy drugs (irinotecan and epirubicin) for people whose bladder cancer has come back after prior treatment with a similar drug. The goal is to see if this combination can help shrink or control the cancer.
ChongqingAges 18 years+ - NCT07268261Recruiting
New surgery for chronic anal fissure
This trial tests a new combined surgical method for people with a chronic anal fissure (a small tear in the skin around the anus) that has not healed and is causing muscle spasms. The goal is to see if this surgery can help the fissure heal and relieve pain and spasm.
MoscowAges 18–70 - NCT07261553Recruiting
Exercises at home for muscle and bone conditions
This study looks at how well people follow a home exercise program for muscle or bone problems. It aims to understand what helps or makes it hard to stick with the exercises.
Konya, KonyaAges 18 years+ - NCT07260812RecruitingPhase 1
KSV01 injection for relapsed DLBCL
This study tests a new injection called KSV01 for people with a type of lymphoma (DLBCL) that has returned or not responded to previous treatments. The goal is to see if it can help shrink tumors or stop the disease from getting worse.
Wuhan, HubeiAges 18–65 - NCT07265349RecruitingPhase 1/Phase 2
Stem cells plus bypass surgery for chronic heart failure
This trial tests whether injecting stem cells from umbilical cord tissue into the heart muscle during bypass surgery can improve heart function in people with chronic heart failure. It is for patients who are already scheduled for bypass surgery and have a weakened heart pump (LVEF between 21% and 40%).
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07264595RecruitingPhase 1/Phase 2
Study of GS3-007a for children with growth hormone deficiency
This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.
Wuhan, HubeiAges 3 years+ - NCT07266805RecruitingPhase 3
Oral treatment for acquired angioedema due to C1 inhibitor deficiency
This study tests an oral medication that can be taken daily to prevent angioedema attacks and as a rescue treatment when attacks occur. It may help reduce the frequency and severity of swelling episodes.
San Diego, CaliforniaAges 18 years+
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,322 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.